The inflammatory component in progressive renal disease - Are interventions possible?

Nephrology Dialysis Transplantation

Volumn 17, Issue 3, 2002, Pages 363-368

  Noronha, Irene L ^a   Fujihara, Clarice K ^a   Zatz, Roberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; GAMMA INTERFERON; LAMININ; MACROPHAGE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOPONTIN; RANTES; STEROID;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FIBROGENESIS; HUMAN; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KIDNEY DISEASE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0036198939     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.3.363     Document Type: Article

References (43)

1. On the pathogenesis of chronic renal failure in primary glomerulopathies: A view from the interstitium
2. Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage
3. Intraglomerular T cell and monocytes in nephritis, study with monoclonal antibodies
4. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
5. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
6. Local macrophage and myofibroblasts proliferation in progressive renal injury in the rat remnant kidney
7. Transdifferentiation: A new angle on renal fibrosis
8. The antigen presentation function of renal tubular epithelial cells
9. Fibronectin production by human tubular cells: The effect of apical protein
10. Understanding the nature of renal disease progression
11. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts
12. Increased expression of transforming growth factor-beta in renal disease
13. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
14. Myofibroblasts and the progression of experimental glomerulonephritis
15. Angiotensin II as a renal growth factor
16. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells
17. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
18. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension
19. Renal injury from angiotensin II-mediated hypertension
20. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis
21. Enhanced interstitial expression of angiotensin II and TGFβ in the renal ablation model: Effect of mycophenolate mofetil
22. Factors affecting progression in advanced chronic renal failure
23. Renal protective effect of enalapril in diabetic nephropathy
24. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial
25. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
26. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
27. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass
28. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis
29. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system
30. Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney
31. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
32. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation
33. Prevention of functional, structural and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor
34. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis
35. Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
36. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
37. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
38. Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model
39. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy
40. Successful mycophenolate mofetil treatment of glomerular disease
41. Combining an atiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals
42. Association of mycophenolate mofetil with an angiotensin II antagonist arrests ongoing renal injury in the remnant kidney
43. Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney